$16.390
+1.972 (+12.03%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
该买入 BlossomHill Therapeutics Inc 股票吗？
BlossomHill Therapeutics, Inc. is a good buy right now due to its recent FDA Fast Track designation for BH-30643, which has shown a 45% objective response rate in clinical trials. The current price is $14.63, significantly lower than the analyst price target of $40, indicating substantial upside potential. However, the company is currently facing a risk with a negative net income of -$23,758,000 in Q2 2026, which investors should monitor closely.
BLSM 股价于 Monday 收于 $16.39，此前上涨 +12.03%
BlossomHill Therapeutics Inc (BLSM) last closed at $16.3899994, gaining +12.03%. These facts feed the 1-day and 1-week BLSM price prediction above.
预测驱动因素
BlossomHill Therapeutics Inc（BLSM）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
BLSM 季节性分析
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。